Fig. 6. Significant changes in lipid metabolites induced by LPC or LPA treatment.
18:0 LPC or 18:0 LPA was administered subcutaneously at 2 h and 14 h post-CLP at the dose of 10 mg/kg. At 24 h after sham or CLP operation, plasma was prepared from blood obtained from retro-orbital plexus. Significant changes common to LPC or LPA treatment (A), significant changes observed only in LPC treatment (B), and significant changes observed only in LPA treatment (C).